nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP2B6—Sorafenib—thyroid cancer	0.0657	0.17	CbGbCtD
Nicotine—CYP2C8—Sorafenib—thyroid cancer	0.0498	0.129	CbGbCtD
Nicotine—CYP2C19—Sorafenib—thyroid cancer	0.0417	0.108	CbGbCtD
Nicotine—CYP2B6—Doxorubicin—thyroid cancer	0.0399	0.103	CbGbCtD
Nicotine—CYP1A2—Sorafenib—thyroid cancer	0.0385	0.0995	CbGbCtD
Nicotine—CYP2C9—Sorafenib—thyroid cancer	0.0347	0.0896	CbGbCtD
Nicotine—CYP3A4—Vandetanib—thyroid cancer	0.0335	0.0865	CbGbCtD
Nicotine—CYP2D6—Sorafenib—thyroid cancer	0.0317	0.082	CbGbCtD
Nicotine—CYP3A4—Sorafenib—thyroid cancer	0.0202	0.0521	CbGbCtD
Nicotine—CYP2D6—Doxorubicin—thyroid cancer	0.0193	0.0497	CbGbCtD
Nicotine—SLC22A4—larynx—thyroid cancer	0.0149	0.0911	CbGeAlD
Nicotine—CYP3A4—Doxorubicin—thyroid cancer	0.0122	0.0316	CbGbCtD
Nicotine—CHRNA5—thyroid gland—thyroid cancer	0.0078	0.0476	CbGeAlD
Nicotine—CHRNA5—head—thyroid cancer	0.00692	0.0422	CbGeAlD
Nicotine—CHRNB3—head—thyroid cancer	0.00629	0.0384	CbGeAlD
Nicotine—CHRNB2—saliva-secreting gland—thyroid cancer	0.00557	0.034	CbGeAlD
Nicotine—CHRNA6—head—thyroid cancer	0.00525	0.032	CbGeAlD
Nicotine—CHRNA5—lymph node—thyroid cancer	0.00485	0.0296	CbGeAlD
Nicotine—CHRNB4—head—thyroid cancer	0.00476	0.0291	CbGeAlD
Nicotine—CHRNA7—neck—thyroid cancer	0.00452	0.0276	CbGeAlD
Nicotine—CHAT—head—thyroid cancer	0.00436	0.0266	CbGeAlD
Nicotine—CHRNB2—trachea—thyroid cancer	0.00429	0.0262	CbGeAlD
Nicotine—CHRNA10—head—thyroid cancer	0.00419	0.0256	CbGeAlD
Nicotine—SLC22A4—neck—thyroid cancer	0.00396	0.0242	CbGeAlD
Nicotine—CHRNB2—thyroid gland—thyroid cancer	0.0034	0.0207	CbGeAlD
Nicotine—CHRFAM7A—trachea—thyroid cancer	0.00337	0.0205	CbGeAlD
Nicotine—CHRNA2—thyroid gland—thyroid cancer	0.00306	0.0187	CbGeAlD
Nicotine—CHRNB2—head—thyroid cancer	0.00301	0.0184	CbGeAlD
Nicotine—CHRNA10—lymph node—thyroid cancer	0.00294	0.0179	CbGeAlD
Nicotine—CHRNA3—head—thyroid cancer	0.00292	0.0178	CbGeAlD
Nicotine—MAOA—neck—thyroid cancer	0.00284	0.0174	CbGeAlD
Nicotine—SLC22A3—saliva-secreting gland—thyroid cancer	0.00281	0.0171	CbGeAlD
Nicotine—CHRNA2—head—thyroid cancer	0.00272	0.0166	CbGeAlD
Nicotine—CHRFAM7A—thyroid gland—thyroid cancer	0.00266	0.0163	CbGeAlD
Nicotine—MAOB—saliva-secreting gland—thyroid cancer	0.0026	0.0159	CbGeAlD
Nicotine—SLC22A4—trachea—thyroid cancer	0.00238	0.0145	CbGeAlD
Nicotine—CHRFAM7A—head—thyroid cancer	0.00236	0.0144	CbGeAlD
Nicotine—MAOA—saliva-secreting gland—thyroid cancer	0.00222	0.0135	CbGeAlD
Nicotine—CHRNA7—thyroid gland—thyroid cancer	0.00215	0.0131	CbGeAlD
Nicotine—CHRNB2—lymph node—thyroid cancer	0.00211	0.0129	CbGeAlD
Nicotine—CHRNA3—lymph node—thyroid cancer	0.00205	0.0125	CbGeAlD
Nicotine—SLC22A5—saliva-secreting gland—thyroid cancer	0.00204	0.0125	CbGeAlD
Nicotine—CHRNA7—head—thyroid cancer	0.00191	0.0116	CbGeAlD
Nicotine—SLC22A4—thyroid gland—thyroid cancer	0.00188	0.0115	CbGeAlD
Nicotine—CHRNA4—head—thyroid cancer	0.00188	0.0115	CbGeAlD
Nicotine—SLC22A3—thyroid gland—thyroid cancer	0.00171	0.0105	CbGeAlD
Nicotine—MAOA—trachea—thyroid cancer	0.00171	0.0104	CbGeAlD
Nicotine—CYP19A1—thyroid gland—thyroid cancer	0.00169	0.0103	CbGeAlD
Nicotine—SLC22A1—head—thyroid cancer	0.00159	0.00971	CbGeAlD
Nicotine—MAOB—thyroid gland—thyroid cancer	0.00159	0.00968	CbGeAlD
Nicotine—SLC22A5—trachea—thyroid cancer	0.00158	0.00962	CbGeAlD
Nicotine—SLC22A3—head—thyroid cancer	0.00152	0.00928	CbGeAlD
Nicotine—CYP19A1—head—thyroid cancer	0.0015	0.00913	CbGeAlD
Nicotine—CYP1A1—trachea—thyroid cancer	0.00141	0.00859	CbGeAlD
Nicotine—MAOB—head—thyroid cancer	0.00141	0.00859	CbGeAlD
Nicotine—MAOA—thyroid gland—thyroid cancer	0.00135	0.00826	CbGeAlD
Nicotine—SLC22A5—thyroid gland—thyroid cancer	0.00125	0.00761	CbGeAlD
Nicotine—Dysphonia—Epirubicin—thyroid cancer	0.00122	0.00365	CcSEcCtD
Nicotine—Arrhythmia—Sorafenib—thyroid cancer	0.00122	0.00364	CcSEcCtD
Nicotine—MAOA—head—thyroid cancer	0.0012	0.00733	CbGeAlD
Nicotine—Mental disorder—Sorafenib—thyroid cancer	0.0012	0.00357	CcSEcCtD
Nicotine—Erythema—Sorafenib—thyroid cancer	0.00119	0.00355	CcSEcCtD
Nicotine—Gingivitis—Doxorubicin—thyroid cancer	0.00119	0.00354	CcSEcCtD
Nicotine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00118	0.00351	CcSEcCtD
Nicotine—SLC22A4—lymph node—thyroid cancer	0.00117	0.00714	CbGeAlD
Nicotine—Dysgeusia—Sorafenib—thyroid cancer	0.00117	0.00348	CcSEcCtD
Nicotine—Muscle spasms—Sorafenib—thyroid cancer	0.00115	0.00341	CcSEcCtD
Nicotine—Body temperature increased—Vandetanib—thyroid cancer	0.00114	0.0034	CcSEcCtD
Nicotine—Abdominal pain—Vandetanib—thyroid cancer	0.00114	0.0034	CcSEcCtD
Nicotine—Dysphonia—Doxorubicin—thyroid cancer	0.00113	0.00338	CcSEcCtD
Nicotine—CYP1A2—thyroid gland—thyroid cancer	0.00113	0.00689	CbGeAlD
Nicotine—CYP1A1—thyroid gland—thyroid cancer	0.00111	0.0068	CbGeAlD
Nicotine—Lacrimation increased—Epirubicin—thyroid cancer	0.00109	0.00326	CcSEcCtD
Nicotine—Angioedema—Sorafenib—thyroid cancer	0.00109	0.00325	CcSEcCtD
Nicotine—Syncope—Sorafenib—thyroid cancer	0.00107	0.00318	CcSEcCtD
Nicotine—SLC22A3—lymph node—thyroid cancer	0.00106	0.0065	CbGeAlD
Nicotine—Loss of consciousness—Sorafenib—thyroid cancer	0.00105	0.00312	CcSEcCtD
Nicotine—CYP19A1—lymph node—thyroid cancer	0.00105	0.00639	CbGeAlD
Nicotine—Cough—Sorafenib—thyroid cancer	0.00104	0.0031	CcSEcCtD
Nicotine—Asthenia—Vandetanib—thyroid cancer	0.00103	0.00308	CcSEcCtD
Nicotine—Hypertension—Sorafenib—thyroid cancer	0.00103	0.00307	CcSEcCtD
Nicotine—Coordination abnormal—Epirubicin—thyroid cancer	0.00103	0.00306	CcSEcCtD
Nicotine—Pruritus—Vandetanib—thyroid cancer	0.00102	0.00304	CcSEcCtD
Nicotine—CYP2E1—thyroid gland—thyroid cancer	0.00102	0.0062	CbGeAlD
Nicotine—Myalgia—Sorafenib—thyroid cancer	0.00101	0.00302	CcSEcCtD
Nicotine—Arthralgia—Sorafenib—thyroid cancer	0.00101	0.00302	CcSEcCtD
Nicotine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00101	0.00301	CcSEcCtD
Nicotine—Hiccups—Epirubicin—thyroid cancer	0.00101	0.003	CcSEcCtD
Nicotine—Abnormal dreams—Epirubicin—thyroid cancer	0.000996	0.00297	CcSEcCtD
Nicotine—Dry mouth—Sorafenib—thyroid cancer	0.000992	0.00296	CcSEcCtD
Nicotine—Eructation—Epirubicin—thyroid cancer	0.00099	0.00295	CcSEcCtD
Nicotine—CYP1A1—head—thyroid cancer	0.000988	0.00603	CbGeAlD
Nicotine—Diarrhoea—Vandetanib—thyroid cancer	0.000987	0.00294	CcSEcCtD
Nicotine—MAOB—lymph node—thyroid cancer	0.000986	0.00601	CbGeAlD
Nicotine—Cystitis noninfective—Epirubicin—thyroid cancer	0.000984	0.00293	CcSEcCtD
Nicotine—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000979	0.00292	CcSEcCtD
Nicotine—Influenza like illness—Epirubicin—thyroid cancer	0.000979	0.00292	CcSEcCtD
Nicotine—Cystitis—Epirubicin—thyroid cancer	0.000973	0.0029	CcSEcCtD
Nicotine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000973	0.0029	CcSEcCtD
Nicotine—CYP2B6—head—thyroid cancer	0.00096	0.00586	CbGeAlD
Nicotine—Shock—Sorafenib—thyroid cancer	0.000957	0.00285	CcSEcCtD
Nicotine—Fluid retention—Epirubicin—thyroid cancer	0.000957	0.00285	CcSEcCtD
Nicotine—Nervous system disorder—Sorafenib—thyroid cancer	0.000954	0.00284	CcSEcCtD
Nicotine—Dizziness—Vandetanib—thyroid cancer	0.000954	0.00284	CcSEcCtD
Nicotine—Coordination abnormal—Doxorubicin—thyroid cancer	0.00095	0.00283	CcSEcCtD
Nicotine—Hiccups—Doxorubicin—thyroid cancer	0.000932	0.00278	CcSEcCtD
Nicotine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000926	0.00276	CcSEcCtD
Nicotine—Abnormal dreams—Doxorubicin—thyroid cancer	0.000921	0.00275	CcSEcCtD
Nicotine—Vomiting—Vandetanib—thyroid cancer	0.000917	0.00273	CcSEcCtD
Nicotine—Eructation—Doxorubicin—thyroid cancer	0.000916	0.00273	CcSEcCtD
Nicotine—Bladder pain—Epirubicin—thyroid cancer	0.000911	0.00271	CcSEcCtD
Nicotine—Mouth ulceration—Epirubicin—thyroid cancer	0.000911	0.00271	CcSEcCtD
Nicotine—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000911	0.00271	CcSEcCtD
Nicotine—Rash—Vandetanib—thyroid cancer	0.000909	0.00271	CcSEcCtD
Nicotine—Dermatitis—Vandetanib—thyroid cancer	0.000908	0.00271	CcSEcCtD
Nicotine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000906	0.0027	CcSEcCtD
Nicotine—Influenza like illness—Doxorubicin—thyroid cancer	0.000906	0.0027	CcSEcCtD
Nicotine—Headache—Vandetanib—thyroid cancer	0.000903	0.00269	CcSEcCtD
Nicotine—CYP2E1—head—thyroid cancer	0.000901	0.0055	CbGeAlD
Nicotine—Cystitis—Doxorubicin—thyroid cancer	0.0009	0.00268	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000886	0.00264	CcSEcCtD
Nicotine—Fluid retention—Doxorubicin—thyroid cancer	0.000885	0.00264	CcSEcCtD
Nicotine—Abnormal vision—Epirubicin—thyroid cancer	0.000879	0.00262	CcSEcCtD
Nicotine—Mental disability—Epirubicin—thyroid cancer	0.000874	0.00261	CcSEcCtD
Nicotine—Dyspnoea—Sorafenib—thyroid cancer	0.000867	0.00258	CcSEcCtD
Nicotine—Nausea—Vandetanib—thyroid cancer	0.000857	0.00255	CcSEcCtD
Nicotine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000857	0.00255	CcSEcCtD
Nicotine—Dyspepsia—Sorafenib—thyroid cancer	0.000856	0.00255	CcSEcCtD
Nicotine—Mouth ulceration—Doxorubicin—thyroid cancer	0.000843	0.00251	CcSEcCtD
Nicotine—Bladder pain—Doxorubicin—thyroid cancer	0.000843	0.00251	CcSEcCtD
Nicotine—MAOA—lymph node—thyroid cancer	0.000841	0.00513	CbGeAlD
Nicotine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00084	0.0025	CcSEcCtD
Nicotine—Fatigue—Sorafenib—thyroid cancer	0.000839	0.0025	CcSEcCtD
Nicotine—Pain—Sorafenib—thyroid cancer	0.000832	0.00248	CcSEcCtD
Nicotine—Constipation—Sorafenib—thyroid cancer	0.000832	0.00248	CcSEcCtD
Nicotine—Abnormal vision—Doxorubicin—thyroid cancer	0.000813	0.00242	CcSEcCtD
Nicotine—Mental disability—Doxorubicin—thyroid cancer	0.000809	0.00241	CcSEcCtD
Nicotine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000796	0.00237	CcSEcCtD
Nicotine—Hot flush—Epirubicin—thyroid cancer	0.000782	0.00233	CcSEcCtD
Nicotine—Increased appetite—Epirubicin—thyroid cancer	0.000779	0.00232	CcSEcCtD
Nicotine—Menopausal symptoms—Epirubicin—thyroid cancer	0.000775	0.00231	CcSEcCtD
Nicotine—SLC22A5—lymph node—thyroid cancer	0.000774	0.00473	CbGeAlD
Nicotine—Urticaria—Sorafenib—thyroid cancer	0.000773	0.0023	CcSEcCtD
Nicotine—Abdominal pain—Sorafenib—thyroid cancer	0.000769	0.00229	CcSEcCtD
Nicotine—Body temperature increased—Sorafenib—thyroid cancer	0.000769	0.00229	CcSEcCtD
Nicotine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000765	0.00228	CcSEcCtD
Nicotine—Cardiac failure—Epirubicin—thyroid cancer	0.00075	0.00223	CcSEcCtD
Nicotine—Hot flush—Doxorubicin—thyroid cancer	0.000724	0.00216	CcSEcCtD
Nicotine—Increased appetite—Doxorubicin—thyroid cancer	0.00072	0.00215	CcSEcCtD
Nicotine—Affect lability—Epirubicin—thyroid cancer	0.00072	0.00215	CcSEcCtD
Nicotine—Migraine—Epirubicin—thyroid cancer	0.00072	0.00215	CcSEcCtD
Nicotine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000717	0.00214	CcSEcCtD
Nicotine—Hypersensitivity—Sorafenib—thyroid cancer	0.000717	0.00214	CcSEcCtD
Nicotine—CYP2D6—head—thyroid cancer	0.000714	0.00435	CbGeAlD
Nicotine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000708	0.00211	CcSEcCtD
Nicotine—Asthenia—Sorafenib—thyroid cancer	0.000698	0.00208	CcSEcCtD
Nicotine—Cardiac failure—Doxorubicin—thyroid cancer	0.000694	0.00207	CcSEcCtD
Nicotine—Mood swings—Epirubicin—thyroid cancer	0.000693	0.00206	CcSEcCtD
Nicotine—CYP1A1—lymph node—thyroid cancer	0.000692	0.00422	CbGeAlD
Nicotine—Pruritus—Sorafenib—thyroid cancer	0.000688	0.00205	CcSEcCtD
Nicotine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000668	0.00199	CcSEcCtD
Nicotine—Affect lability—Doxorubicin—thyroid cancer	0.000666	0.00198	CcSEcCtD
Nicotine—Migraine—Doxorubicin—thyroid cancer	0.000666	0.00198	CcSEcCtD
Nicotine—Diarrhoea—Sorafenib—thyroid cancer	0.000666	0.00198	CcSEcCtD
Nicotine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000654	0.00195	CcSEcCtD
Nicotine—Dizziness—Sorafenib—thyroid cancer	0.000643	0.00192	CcSEcCtD
Nicotine—Mood swings—Doxorubicin—thyroid cancer	0.000641	0.00191	CcSEcCtD
Nicotine—Influenza—Epirubicin—thyroid cancer	0.000632	0.00188	CcSEcCtD
Nicotine—Dysphagia—Epirubicin—thyroid cancer	0.000632	0.00188	CcSEcCtD
Nicotine—Vomiting—Sorafenib—thyroid cancer	0.000619	0.00184	CcSEcCtD
Nicotine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000618	0.00184	CcSEcCtD
Nicotine—Rash—Sorafenib—thyroid cancer	0.000613	0.00183	CcSEcCtD
Nicotine—Dermatitis—Sorafenib—thyroid cancer	0.000613	0.00183	CcSEcCtD
Nicotine—Headache—Sorafenib—thyroid cancer	0.000609	0.00182	CcSEcCtD
Nicotine—Bronchitis—Epirubicin—thyroid cancer	0.000608	0.00181	CcSEcCtD
Nicotine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000605	0.0018	CcSEcCtD
Nicotine—Influenza—Doxorubicin—thyroid cancer	0.000585	0.00174	CcSEcCtD
Nicotine—Dysphagia—Doxorubicin—thyroid cancer	0.000585	0.00174	CcSEcCtD
Nicotine—Nausea—Sorafenib—thyroid cancer	0.000578	0.00172	CcSEcCtD
Nicotine—Weight increased—Epirubicin—thyroid cancer	0.000575	0.00171	CcSEcCtD
Nicotine—Bronchitis—Doxorubicin—thyroid cancer	0.000563	0.00168	CcSEcCtD
Nicotine—Stomatitis—Epirubicin—thyroid cancer	0.000549	0.00164	CcSEcCtD
Nicotine—Weight increased—Doxorubicin—thyroid cancer	0.000532	0.00159	CcSEcCtD
Nicotine—Epistaxis—Epirubicin—thyroid cancer	0.000532	0.00158	CcSEcCtD
Nicotine—Sinusitis—Epirubicin—thyroid cancer	0.000529	0.00158	CcSEcCtD
Nicotine—Stomatitis—Doxorubicin—thyroid cancer	0.000508	0.00151	CcSEcCtD
Nicotine—Rhinitis—Epirubicin—thyroid cancer	0.000507	0.00151	CcSEcCtD
Nicotine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000504	0.0015	CcSEcCtD
Nicotine—Pharyngitis—Epirubicin—thyroid cancer	0.000502	0.0015	CcSEcCtD
Nicotine—Oedema peripheral—Epirubicin—thyroid cancer	0.000499	0.00149	CcSEcCtD
Nicotine—Epistaxis—Doxorubicin—thyroid cancer	0.000492	0.00147	CcSEcCtD
Nicotine—Sinusitis—Doxorubicin—thyroid cancer	0.000489	0.00146	CcSEcCtD
Nicotine—Visual impairment—Epirubicin—thyroid cancer	0.000488	0.00145	CcSEcCtD
Nicotine—Flushing—Epirubicin—thyroid cancer	0.00047	0.0014	CcSEcCtD
Nicotine—Cardiac disorder—Epirubicin—thyroid cancer	0.00047	0.0014	CcSEcCtD
Nicotine—Rhinitis—Doxorubicin—thyroid cancer	0.000469	0.0014	CcSEcCtD
Nicotine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000466	0.00139	CcSEcCtD
Nicotine—Pharyngitis—Doxorubicin—thyroid cancer	0.000465	0.00138	CcSEcCtD
Nicotine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000461	0.00137	CcSEcCtD
Nicotine—Immune system disorder—Epirubicin—thyroid cancer	0.000457	0.00136	CcSEcCtD
Nicotine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000456	0.00136	CcSEcCtD
Nicotine—Arrhythmia—Epirubicin—thyroid cancer	0.000452	0.00135	CcSEcCtD
Nicotine—Visual impairment—Doxorubicin—thyroid cancer	0.000451	0.00134	CcSEcCtD
Nicotine—Mental disorder—Epirubicin—thyroid cancer	0.000443	0.00132	CcSEcCtD
Nicotine—Erythema—Epirubicin—thyroid cancer	0.000441	0.00131	CcSEcCtD
Nicotine—Flushing—Doxorubicin—thyroid cancer	0.000435	0.00129	CcSEcCtD
Nicotine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000435	0.00129	CcSEcCtD
Nicotine—Flatulence—Epirubicin—thyroid cancer	0.000434	0.00129	CcSEcCtD
Nicotine—Tension—Epirubicin—thyroid cancer	0.000432	0.00129	CcSEcCtD
Nicotine—Dysgeusia—Epirubicin—thyroid cancer	0.000431	0.00129	CcSEcCtD
Nicotine—Nervousness—Epirubicin—thyroid cancer	0.000428	0.00127	CcSEcCtD
Nicotine—Back pain—Epirubicin—thyroid cancer	0.000426	0.00127	CcSEcCtD
Nicotine—Muscle spasms—Epirubicin—thyroid cancer	0.000424	0.00126	CcSEcCtD
Nicotine—Immune system disorder—Doxorubicin—thyroid cancer	0.000423	0.00126	CcSEcCtD
Nicotine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000422	0.00126	CcSEcCtD
Nicotine—Arrhythmia—Doxorubicin—thyroid cancer	0.000418	0.00125	CcSEcCtD
Nicotine—Mental disorder—Doxorubicin—thyroid cancer	0.00041	0.00122	CcSEcCtD
Nicotine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000409	0.00122	CcSEcCtD
Nicotine—Erythema—Doxorubicin—thyroid cancer	0.000408	0.00121	CcSEcCtD
Nicotine—Agitation—Epirubicin—thyroid cancer	0.000405	0.00121	CcSEcCtD
Nicotine—Flatulence—Doxorubicin—thyroid cancer	0.000402	0.0012	CcSEcCtD
Nicotine—Tension—Doxorubicin—thyroid cancer	0.0004	0.00119	CcSEcCtD
Nicotine—Dysgeusia—Doxorubicin—thyroid cancer	0.000399	0.00119	CcSEcCtD
Nicotine—Malaise—Epirubicin—thyroid cancer	0.000397	0.00118	CcSEcCtD
Nicotine—Nervousness—Doxorubicin—thyroid cancer	0.000396	0.00118	CcSEcCtD
Nicotine—Vertigo—Epirubicin—thyroid cancer	0.000396	0.00118	CcSEcCtD
Nicotine—Syncope—Epirubicin—thyroid cancer	0.000395	0.00118	CcSEcCtD
Nicotine—Back pain—Doxorubicin—thyroid cancer	0.000394	0.00117	CcSEcCtD
Nicotine—Muscle spasms—Doxorubicin—thyroid cancer	0.000392	0.00117	CcSEcCtD
Nicotine—Palpitations—Epirubicin—thyroid cancer	0.000389	0.00116	CcSEcCtD
Nicotine—Loss of consciousness—Epirubicin—thyroid cancer	0.000387	0.00115	CcSEcCtD
Nicotine—Cough—Epirubicin—thyroid cancer	0.000384	0.00115	CcSEcCtD
Nicotine—Convulsion—Epirubicin—thyroid cancer	0.000382	0.00114	CcSEcCtD
Nicotine—Hypertension—Epirubicin—thyroid cancer	0.00038	0.00113	CcSEcCtD
Nicotine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000378	0.00113	CcSEcCtD
Nicotine—Chest pain—Epirubicin—thyroid cancer	0.000375	0.00112	CcSEcCtD
Nicotine—Arthralgia—Epirubicin—thyroid cancer	0.000375	0.00112	CcSEcCtD
Nicotine—Myalgia—Epirubicin—thyroid cancer	0.000375	0.00112	CcSEcCtD
Nicotine—Agitation—Doxorubicin—thyroid cancer	0.000375	0.00112	CcSEcCtD
Nicotine—Anxiety—Epirubicin—thyroid cancer	0.000374	0.00111	CcSEcCtD
Nicotine—Discomfort—Epirubicin—thyroid cancer	0.000371	0.0011	CcSEcCtD
Nicotine—Malaise—Doxorubicin—thyroid cancer	0.000368	0.0011	CcSEcCtD
Nicotine—Dry mouth—Epirubicin—thyroid cancer	0.000367	0.00109	CcSEcCtD
Nicotine—Vertigo—Doxorubicin—thyroid cancer	0.000366	0.00109	CcSEcCtD
Nicotine—Syncope—Doxorubicin—thyroid cancer	0.000366	0.00109	CcSEcCtD
Nicotine—Confusional state—Epirubicin—thyroid cancer	0.000363	0.00108	CcSEcCtD
Nicotine—Palpitations—Doxorubicin—thyroid cancer	0.00036	0.00107	CcSEcCtD
Nicotine—Oedema—Epirubicin—thyroid cancer	0.00036	0.00107	CcSEcCtD
Nicotine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00036	0.00107	CcSEcCtD
Nicotine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000358	0.00107	CcSEcCtD
Nicotine—Cough—Doxorubicin—thyroid cancer	0.000356	0.00106	CcSEcCtD
Nicotine—Shock—Epirubicin—thyroid cancer	0.000354	0.00105	CcSEcCtD
Nicotine—Convulsion—Doxorubicin—thyroid cancer	0.000353	0.00105	CcSEcCtD
Nicotine—Nervous system disorder—Epirubicin—thyroid cancer	0.000353	0.00105	CcSEcCtD
Nicotine—Hypertension—Doxorubicin—thyroid cancer	0.000352	0.00105	CcSEcCtD
Nicotine—Tachycardia—Epirubicin—thyroid cancer	0.000351	0.00105	CcSEcCtD
Nicotine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000348	0.00104	CcSEcCtD
Nicotine—Arthralgia—Doxorubicin—thyroid cancer	0.000347	0.00103	CcSEcCtD
Nicotine—Chest pain—Doxorubicin—thyroid cancer	0.000347	0.00103	CcSEcCtD
Nicotine—Myalgia—Doxorubicin—thyroid cancer	0.000347	0.00103	CcSEcCtD
Nicotine—Anxiety—Doxorubicin—thyroid cancer	0.000346	0.00103	CcSEcCtD
Nicotine—Discomfort—Doxorubicin—thyroid cancer	0.000343	0.00102	CcSEcCtD
Nicotine—Dry mouth—Doxorubicin—thyroid cancer	0.000339	0.00101	CcSEcCtD
Nicotine—Hypotension—Epirubicin—thyroid cancer	0.000336	0.001	CcSEcCtD
Nicotine—Confusional state—Doxorubicin—thyroid cancer	0.000335	0.000999	CcSEcCtD
Nicotine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000333	0.000991	CcSEcCtD
Nicotine—Oedema—Doxorubicin—thyroid cancer	0.000333	0.000991	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000328	0.000976	CcSEcCtD
Nicotine—Shock—Doxorubicin—thyroid cancer	0.000327	0.000975	CcSEcCtD
Nicotine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000326	0.000972	CcSEcCtD
Nicotine—Insomnia—Epirubicin—thyroid cancer	0.000325	0.000969	CcSEcCtD
Nicotine—Tachycardia—Doxorubicin—thyroid cancer	0.000325	0.000967	CcSEcCtD
Nicotine—Paraesthesia—Epirubicin—thyroid cancer	0.000323	0.000962	CcSEcCtD
Nicotine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000322	0.000958	CcSEcCtD
Nicotine—Dyspnoea—Epirubicin—thyroid cancer	0.000321	0.000955	CcSEcCtD
Nicotine—Somnolence—Epirubicin—thyroid cancer	0.00032	0.000952	CcSEcCtD
Nicotine—Dyspepsia—Epirubicin—thyroid cancer	0.000316	0.000943	CcSEcCtD
Nicotine—Hypotension—Doxorubicin—thyroid cancer	0.000311	0.000926	CcSEcCtD
Nicotine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00031	0.000925	CcSEcCtD
Nicotine—Fatigue—Epirubicin—thyroid cancer	0.00031	0.000924	CcSEcCtD
Nicotine—Pain—Epirubicin—thyroid cancer	0.000307	0.000916	CcSEcCtD
Nicotine—Constipation—Epirubicin—thyroid cancer	0.000307	0.000916	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000303	0.000903	CcSEcCtD
Nicotine—Insomnia—Doxorubicin—thyroid cancer	0.000301	0.000896	CcSEcCtD
Nicotine—Paraesthesia—Doxorubicin—thyroid cancer	0.000299	0.00089	CcSEcCtD
Nicotine—Dyspnoea—Doxorubicin—thyroid cancer	0.000297	0.000884	CcSEcCtD
Nicotine—Feeling abnormal—Epirubicin—thyroid cancer	0.000296	0.000883	CcSEcCtD
Nicotine—Somnolence—Doxorubicin—thyroid cancer	0.000296	0.000881	CcSEcCtD
Nicotine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000294	0.000876	CcSEcCtD
Nicotine—Dyspepsia—Doxorubicin—thyroid cancer	0.000293	0.000872	CcSEcCtD
Nicotine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000287	0.000856	CcSEcCtD
Nicotine—Fatigue—Doxorubicin—thyroid cancer	0.000287	0.000855	CcSEcCtD
Nicotine—Urticaria—Epirubicin—thyroid cancer	0.000286	0.000851	CcSEcCtD
Nicotine—Pain—Doxorubicin—thyroid cancer	0.000284	0.000848	CcSEcCtD
Nicotine—Constipation—Doxorubicin—thyroid cancer	0.000284	0.000848	CcSEcCtD
Nicotine—Abdominal pain—Epirubicin—thyroid cancer	0.000284	0.000847	CcSEcCtD
Nicotine—Body temperature increased—Epirubicin—thyroid cancer	0.000284	0.000847	CcSEcCtD
Nicotine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000274	0.000817	CcSEcCtD
Nicotine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000272	0.000811	CcSEcCtD
Nicotine—Hypersensitivity—Epirubicin—thyroid cancer	0.000265	0.000789	CcSEcCtD
Nicotine—Urticaria—Doxorubicin—thyroid cancer	0.000264	0.000787	CcSEcCtD
Nicotine—Body temperature increased—Doxorubicin—thyroid cancer	0.000263	0.000784	CcSEcCtD
Nicotine—Abdominal pain—Doxorubicin—thyroid cancer	0.000263	0.000784	CcSEcCtD
Nicotine—Asthenia—Epirubicin—thyroid cancer	0.000258	0.000769	CcSEcCtD
Nicotine—Pruritus—Epirubicin—thyroid cancer	0.000254	0.000758	CcSEcCtD
Nicotine—Diarrhoea—Epirubicin—thyroid cancer	0.000246	0.000733	CcSEcCtD
Nicotine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000245	0.00073	CcSEcCtD
Nicotine—Asthenia—Doxorubicin—thyroid cancer	0.000239	0.000711	CcSEcCtD
Nicotine—Dizziness—Epirubicin—thyroid cancer	0.000238	0.000708	CcSEcCtD
Nicotine—Pruritus—Doxorubicin—thyroid cancer	0.000235	0.000701	CcSEcCtD
Nicotine—Vomiting—Epirubicin—thyroid cancer	0.000229	0.000681	CcSEcCtD
Nicotine—Diarrhoea—Doxorubicin—thyroid cancer	0.000228	0.000678	CcSEcCtD
Nicotine—Rash—Epirubicin—thyroid cancer	0.000227	0.000675	CcSEcCtD
Nicotine—Dermatitis—Epirubicin—thyroid cancer	0.000226	0.000675	CcSEcCtD
Nicotine—Headache—Epirubicin—thyroid cancer	0.000225	0.000671	CcSEcCtD
Nicotine—Dizziness—Doxorubicin—thyroid cancer	0.00022	0.000655	CcSEcCtD
Nicotine—Nausea—Epirubicin—thyroid cancer	0.000214	0.000636	CcSEcCtD
Nicotine—Vomiting—Doxorubicin—thyroid cancer	0.000212	0.00063	CcSEcCtD
Nicotine—Rash—Doxorubicin—thyroid cancer	0.00021	0.000625	CcSEcCtD
Nicotine—Dermatitis—Doxorubicin—thyroid cancer	0.00021	0.000624	CcSEcCtD
Nicotine—Headache—Doxorubicin—thyroid cancer	0.000208	0.000621	CcSEcCtD
Nicotine—Nausea—Doxorubicin—thyroid cancer	0.000198	0.000589	CcSEcCtD
Nicotine—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000112	0.00099	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000111	0.00098	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NDUFA13—thyroid cancer	0.000111	0.000978	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00011	0.000974	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.00011	0.000972	CbGpPWpGaD
Nicotine—MAOA—Metabolism—HPGD—thyroid cancer	0.000108	0.000955	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000108	0.000955	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000107	0.000947	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000107	0.000946	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CHST14—thyroid cancer	0.000106	0.000934	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000106	0.000931	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000105	0.00093	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.000105	0.000928	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000105	0.000925	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.000923	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.000923	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000105	0.000922	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CHST14—thyroid cancer	0.000104	0.00092	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.000103	0.000909	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.000908	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	9.95e-05	0.000878	CbGpPWpGaD
Nicotine—MAOB—Metabolism—TPR—thyroid cancer	9.9e-05	0.000874	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	9.86e-05	0.00087	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	9.83e-05	0.000867	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	9.82e-05	0.000866	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PRKAR1A—thyroid cancer	9.74e-05	0.00086	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MINPP1—thyroid cancer	9.71e-05	0.000857	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—BRAF—thyroid cancer	9.54e-05	0.000842	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	9.35e-05	0.000826	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—HRAS—thyroid cancer	9.23e-05	0.000814	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—HPGD—thyroid cancer	9.15e-05	0.000807	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.96e-05	0.000791	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	8.94e-05	0.000789	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MINPP1—thyroid cancer	8.9e-05	0.000786	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NDUFA13—thyroid cancer	8.76e-05	0.000773	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.56e-05	0.000755	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—HPGD—thyroid cancer	8.53e-05	0.000753	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—HRAS—thyroid cancer	8.52e-05	0.000752	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—HRAS—thyroid cancer	8.44e-05	0.000745	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	8.43e-05	0.000744	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CHST14—thyroid cancer	8.41e-05	0.000742	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—HPGD—thyroid cancer	8.4e-05	0.000741	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PPARG—thyroid cancer	8.4e-05	0.000741	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.4e-05	0.000741	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—TPR—thyroid cancer	8.38e-05	0.000739	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NDUFA13—thyroid cancer	8.26e-05	0.000729	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	8.24e-05	0.000727	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CHST14—thyroid cancer	8.23e-05	0.000727	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	8.23e-05	0.000726	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—BRAF—thyroid cancer	8.07e-05	0.000712	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	8.05e-05	0.000711	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	8.05e-05	0.00071	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—HRAS—thyroid cancer	8.01e-05	0.000707	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MINPP1—thyroid cancer	7.95e-05	0.000701	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.83e-05	0.000691	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CHST14—thyroid cancer	7.76e-05	0.000685	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	7.57e-05	0.000668	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—HRAS—thyroid cancer	7.53e-05	0.000664	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—BRAF—thyroid cancer	7.52e-05	0.000664	CbGpPWpGaD
Nicotine—MAOB—Metabolism—SLC5A5—thyroid cancer	7.41e-05	0.000654	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	7.31e-05	0.000645	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MINPP1—thyroid cancer	7.31e-05	0.000645	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MINPP1—thyroid cancer	7.25e-05	0.000639	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PPARG—thyroid cancer	7.14e-05	0.00063	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CHST14—thyroid cancer	7.12e-05	0.000628	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.06e-05	0.000623	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.84e-05	0.000604	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—HPGD—thyroid cancer	6.78e-05	0.000598	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	6.76e-05	0.000596	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—HPGD—thyroid cancer	6.64e-05	0.000586	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTGS2—thyroid cancer	6.61e-05	0.000583	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.58e-05	0.00058	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—HRAS—thyroid cancer	6.53e-05	0.000576	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.5e-05	0.000574	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CHST14—thyroid cancer	6.35e-05	0.000561	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—SLC5A5—thyroid cancer	6.27e-05	0.000553	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—HPGD—thyroid cancer	6.26e-05	0.000552	CbGpPWpGaD
Nicotine—MAOB—Metabolism—RXRA—thyroid cancer	6.23e-05	0.00055	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	6.21e-05	0.000548	CbGpPWpGaD
Nicotine—MAOA—Metabolism—TPR—thyroid cancer	6.21e-05	0.000548	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MINPP1—thyroid cancer	6.19e-05	0.000546	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	6.17e-05	0.000545	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.16e-05	0.000544	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PRKAR1A—thyroid cancer	6.11e-05	0.000539	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—TPR—thyroid cancer	6.06e-05	0.000535	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	5.96e-05	0.000526	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CHST14—thyroid cancer	5.84e-05	0.000516	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CHST14—thyroid cancer	5.79e-05	0.000511	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTEN—thyroid cancer	5.76e-05	0.000509	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HPGD—thyroid cancer	5.74e-05	0.000506	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.73e-05	0.000505	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTGS2—thyroid cancer	5.62e-05	0.000496	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.4e-05	0.000477	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—RXRA—thyroid cancer	5.27e-05	0.000465	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	5.26e-05	0.000465	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TPR—thyroid cancer	5.25e-05	0.000464	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	5.17e-05	0.000456	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HPGD—thyroid cancer	5.12e-05	0.000452	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.08e-05	0.000448	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CHST14—thyroid cancer	4.95e-05	0.000437	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTEN—thyroid cancer	4.9e-05	0.000432	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TPR—thyroid cancer	4.9e-05	0.000432	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.84e-05	0.000427	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TPR—thyroid cancer	4.82e-05	0.000426	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	4.82e-05	0.000425	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.78e-05	0.000422	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	4.75e-05	0.000419	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HPGD—thyroid cancer	4.71e-05	0.000416	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HPGD—thyroid cancer	4.67e-05	0.000412	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.65e-05	0.000411	CbGpPWpGaD
Nicotine—MAOA—Metabolism—SLC5A5—thyroid cancer	4.65e-05	0.00041	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—SLC5A5—thyroid cancer	4.54e-05	0.0004	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.51e-05	0.000398	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—HRAS—thyroid cancer	4.39e-05	0.000387	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.25e-05	0.000375	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.15e-05	0.000367	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.06e-05	0.000359	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HPGD—thyroid cancer	3.99e-05	0.000352	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	3.93e-05	0.000347	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PPARG—thyroid cancer	3.93e-05	0.000347	CbGpPWpGaD
Nicotine—MAOA—Metabolism—RXRA—thyroid cancer	3.91e-05	0.000345	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TPR—thyroid cancer	3.89e-05	0.000343	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	3.83e-05	0.000338	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CHST14—thyroid cancer	3.82e-05	0.000337	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TPR—thyroid cancer	3.81e-05	0.000336	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—RXRA—thyroid cancer	3.81e-05	0.000336	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.79e-05	0.000334	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.75e-05	0.000331	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—HRAS—thyroid cancer	3.71e-05	0.000327	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.71e-05	0.000327	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	3.67e-05	0.000324	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SLC5A5—thyroid cancer	3.61e-05	0.000319	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TPR—thyroid cancer	3.59e-05	0.000317	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	3.54e-05	0.000312	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—HRAS—thyroid cancer	3.46e-05	0.000305	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PPARG—thyroid cancer	3.33e-05	0.000294	CbGpPWpGaD
Nicotine—CHAT—Metabolism—AKT1—thyroid cancer	3.32e-05	0.000293	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—RXRA—thyroid cancer	3.3e-05	0.000292	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TPR—thyroid cancer	3.29e-05	0.000291	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.24e-05	0.000286	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.24e-05	0.000286	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.2e-05	0.000283	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—thyroid cancer	3.09e-05	0.000273	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—RXRA—thyroid cancer	3.08e-05	0.000272	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HPGD—thyroid cancer	3.08e-05	0.000272	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—RXRA—thyroid cancer	3.03e-05	0.000268	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TPR—thyroid cancer	2.94e-05	0.00026	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.94e-05	0.000259	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	2.91e-05	0.000257	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.89e-05	0.000255	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.85e-05	0.000252	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—AKT1—thyroid cancer	2.82e-05	0.000249	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TPR—thyroid cancer	2.71e-05	0.000239	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTEN—thyroid cancer	2.7e-05	0.000238	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SLC5A5—thyroid cancer	2.69e-05	0.000237	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TPR—thyroid cancer	2.68e-05	0.000237	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.66e-05	0.000235	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.64e-05	0.000233	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.62e-05	0.000231	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—thyroid cancer	2.62e-05	0.000231	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.52e-05	0.000222	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PPARG—thyroid cancer	2.47e-05	0.000218	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.47e-05	0.000218	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—RXRA—thyroid cancer	2.45e-05	0.000216	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PPARG—thyroid cancer	2.41e-05	0.000212	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—RXRA—thyroid cancer	2.4e-05	0.000212	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.39e-05	0.000211	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.31e-05	0.000204	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TPR—thyroid cancer	2.29e-05	0.000202	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTEN—thyroid cancer	2.28e-05	0.000201	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—RXRA—thyroid cancer	2.26e-05	0.000199	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.25e-05	0.000199	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.2e-05	0.000194	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.2e-05	0.000194	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PPARG—thyroid cancer	2.09e-05	0.000184	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—RXRA—thyroid cancer	2.07e-05	0.000183	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.06e-05	0.000182	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.04e-05	0.00018	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.02e-05	0.000179	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.02e-05	0.000178	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.01e-05	0.000177	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PPARG—thyroid cancer	1.94e-05	0.000172	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—thyroid cancer	1.94e-05	0.000171	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PPARG—thyroid cancer	1.92e-05	0.000169	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—thyroid cancer	1.89e-05	0.000167	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.88e-05	0.000166	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.85e-05	0.000163	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.8e-05	0.000159	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TPR—thyroid cancer	1.77e-05	0.000156	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.74e-05	0.000154	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.72e-05	0.000151	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.7e-05	0.00015	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTEN—thyroid cancer	1.69e-05	0.000149	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RXRA—thyroid cancer	1.69e-05	0.000149	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTEN—thyroid cancer	1.65e-05	0.000146	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.64e-05	0.000145	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.64e-05	0.000145	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.61e-05	0.000142	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AKT1—thyroid cancer	1.55e-05	0.000137	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.55e-05	0.000136	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.53e-05	0.000135	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000134	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.51e-05	0.000133	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.44e-05	0.000127	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTEN—thyroid cancer	1.43e-05	0.000126	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARG—thyroid cancer	1.43e-05	0.000126	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.4e-05	0.000124	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000118	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000117	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AKT1—thyroid cancer	1.32e-05	0.000116	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTEN—thyroid cancer	1.31e-05	0.000116	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.31e-05	0.000115	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.22e-05	0.000107	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000105	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.17e-05	0.000103	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.12e-05	9.91e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.11e-05	9.82e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.07e-05	9.48e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.06e-05	9.4e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.06e-05	9.36e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTEN—thyroid cancer	1.04e-05	9.17e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTEN—thyroid cancer	9.79e-06	8.64e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AKT1—thyroid cancer	9.76e-06	8.61e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AKT1—thyroid cancer	9.52e-06	8.4e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—thyroid cancer	9.19e-06	8.11e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARG—thyroid cancer	9.1e-06	8.03e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTEN—thyroid cancer	8.98e-06	7.92e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.45e-06	7.46e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.38e-06	7.39e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AKT1—thyroid cancer	8.25e-06	7.28e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTEN—thyroid cancer	8.01e-06	7.07e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AKT1—thyroid cancer	7.69e-06	6.79e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AKT1—thyroid cancer	7.57e-06	6.68e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTEN—thyroid cancer	7.37e-06	6.5e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTEN—thyroid cancer	7.31e-06	6.45e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—thyroid cancer	7.16e-06	6.32e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARG—thyroid cancer	7.02e-06	6.2e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTEN—thyroid cancer	6.24e-06	5.51e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKT1—thyroid cancer	6.11e-06	5.39e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKT1—thyroid cancer	5.99e-06	5.28e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKT1—thyroid cancer	5.64e-06	4.98e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.52e-06	4.88e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKT1—thyroid cancer	5.17e-06	4.57e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.82e-06	4.25e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKT1—thyroid cancer	4.62e-06	4.08e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKT1—thyroid cancer	4.25e-06	3.75e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKT1—thyroid cancer	4.21e-06	3.72e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKT1—thyroid cancer	3.6e-06	3.18e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.78e-06	2.45e-05	CbGpPWpGaD
